Non-classical cardenolides from Calotropis gigantea exhibit anticancer effect as HIF-1 inhibitors

Zhiyuan Zheng,Zhongbo Zhou,Qiulong Zhang,Xiaobo Zhou,Ji Yang,Ming-Rong Yang,Guo-Yuan Zhu,Zhi-Hong Jiang,Ting Li,Qianyu Lin,Li-Ping Bai
DOI: https://doi.org/10.1016/j.bioorg.2021.104740
IF: 5.307
2021-04-01
Bioorganic Chemistry
Abstract:<p>Six new non-classical cardenolides (<strong>1</strong>−<strong>6</strong>), and seventeen known ones (<strong>7</strong>−<strong>23</strong>) were isolated from <em>Calotropis gigantea</em>. All cardenolides showed inhibitory effect on hypoxia inducible factor-1 (HIF-1) transcriptional activity with IC<sub>50</sub> of 8.85 nM−16.69 <em>µ</em>M except <strong>5</strong> and <strong>7</strong>. The novel 19-dihydrocalotoxin (<strong>1</strong>) exhibited a comparable HIF-1 inhibitory activity (IC<sub>50</sub> of 139.57 nM) to digoxin (IC<sub>50</sub> of 145.77 nM), a well-studied HIF-1 inhibitor, and <strong>11</strong>, <strong>12</strong>, <strong>14</strong>, <strong>16</strong> and <strong>19</strong> presented 1.4−15.4 folds stronger HIF-1 inhibition than digoxin. <strong>1</strong> and <strong>11</strong> showed a dose-dependent inhibition on HIF-1<em>α</em> protein, which led to their HIF-1 suppressing effects. Compared with LO2 and H9c2 normal cell lines, both <strong>1</strong> and <strong>11</strong> showed selective cytotoxicity against various cancer cell lines including HCT116, HeLa, HepG2, A549, MCF-7, A2780 and MDA-MB-231. Moreover, a comprehensive structure-activity relationship was concluded for these non-classical cardenolides as HIF-1 inhibitors, which may shed some light on the rational design and development of cardenolide-based anticancer drugs.</p>
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?